CPIG
CGTX icon

Chicago Partners Investment Group’s Cognition Therapeutics CGTX Stock Holding History

Chicago Partners Investment Group’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1K Sell
10,909
-11
-0.1% -$13 ﹤0.01% 1466
2025
Q4 		$15.6K Hold
10,920
– – ﹤0.01% 1292
2025
Q3 		$17.4K Buy
10,920
+120
+1% +$164 ﹤0.01% 1211
2025
Q2 		$8.69K Hold
10,800
– – ﹤0.01% 1094
2025
Q1 		$3.83K Buy
+10,800
New +$6.35K ﹤0.01% 933

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Chicago Partners Investment Group's CGTX Position: Q1 2026 in Review

Chicago Partners Investment Group reduced its Cognition Therapeutics (CGTX) stake by 0.1% in Q1 2026, selling an estimated $13 and leaving 10,909 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

Chicago Partners Investment Group first reported a position in CGTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $17.4K in Q3 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Chicago Partners Investment Group held 10,909 shares of Cognition Therapeutics worth $14.1K as of Q1 2026.
  • Chicago Partners Investment Group sold 11 Cognition Therapeutics shares in Q1 2026, an estimated $13.
  • Cognition Therapeutics made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q1 2026, its #1466 holding.
  • Chicago Partners Investment Group first reported a position in Cognition Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Chicago Partners Investment Group's Cognition Therapeutics position peaked at $17.4K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.